These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38271210)

  • 1. Cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe.
    Gao TY; Tao YT; Li HY; Liu X; Ma YT; Li HJ; Xian-Yu CY; Deng NJ; Leng WD; Luo J; Zhang C
    J Glob Health; 2024 Jan; 14():04014. PubMed ID: 38271210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.
    Mazidimoradi A; Amiri S; Khani Y; Allahqoli L; Salehiniya H
    Thorac Cancer; 2023 Aug; 14(24):2361-2407. PubMed ID: 37455657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
    India State-Level Disease Burden Initiative Cancer Collaborators
    Lancet Oncol; 2018 Oct; 19(10):1289-1306. PubMed ID: 30219626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diseases and Injuries Collaborators
    Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Brain and Other CNS Cancer Collaborators
    Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.
    Lin Z; Gan M; Wang X; Su Z
    Reprod Health; 2024 Oct; 21(1):144. PubMed ID: 39390595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
    GBD 2017 Stomach Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.
    Rezaei F; Mazidimoradi A; Rayatinejad A; Allahqoli L; Salehiniya H
    Thorac Cancer; 2023 Jun; 14(18):1668-1706. PubMed ID: 37127553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Zhou M; Wang H; Zeng X; Yin P; Zhu J; Chen W; Li X; Wang L; Wang L; Liu Y; Liu J; Zhang M; Qi J; Yu S; Afshin A; Gakidou E; Glenn S; Krish VS; Miller-Petrie MK; Mountjoy-Venning WC; Mullany EC; Redford SB; Liu H; Naghavi M; Hay SI; Wang L; Murray CJL; Liang X
    Lancet; 2019 Sep; 394(10204):1145-1158. PubMed ID: 31248666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, prevalence, mortality, disability-adjusted life years and risk factors of cancer in Australia and comparison with OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015.
    Melaku YA; Appleton SL; Gill TK; Ogbo FA; Buckley E; Shi Z; Driscoll T; Adams R; Cowie BC; Fitzmaurice C
    Cancer Epidemiol; 2018 Feb; 52():43-54. PubMed ID: 29216565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.
    He H; Liu Q; Li N; Guo L; Gao F; Bai L; Gao F; Lyu J
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e91. PubMed ID: 31928566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national cancer burdens of respiratory and digestive tracts in 1990-2044: A cross-sectional and age-period-cohort forecast study.
    Jin W; Huang K; Zhang M; Gao W; Luo Q; Ye X; Yuan Z
    Cancer Epidemiol; 2024 Aug; 91():102583. PubMed ID: 38815482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of brain and central nervous system cancers in Asia from 1990 to 2019 and its predicted level in the next twenty-five years : Burden and prediction model of CNS cancers in Asia.
    Liu X; Cheng LC; Gao TY; Luo J; Zhang C
    BMC Public Health; 2023 Dec; 23(1):2522. PubMed ID: 38104107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study.
    Zhang G; Yu C; Zhou M; Wang L; Zhang Y; Luo L
    BMC Cardiovasc Disord; 2018 Feb; 18(1):18. PubMed ID: 29390974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990-2017: an analysis for the Global Burden of Disease Study 2017.
    Yin P; Brauer M; Cohen AJ; Wang H; Li J; Burnett RT; Stanaway JD; Causey K; Larson S; Godwin W; Frostad J; Marks A; Wang L; Zhou M; Murray CJL
    Lancet Planet Health; 2020 Sep; 4(9):e386-e398. PubMed ID: 32818429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.
    Yang G; Wang Y; Zeng Y; Gao GF; Liang X; Zhou M; Wan X; Yu S; Jiang Y; Naghavi M; Vos T; Wang H; Lopez AD; Murray CJ
    Lancet; 2013 Jun; 381(9882):1987-2015. PubMed ID: 23746901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DALYs for breast cancer in China, 2000-2050: trend analysis and prediction based on GBD 2019].
    Yan XX; Li YJ; Cao MD; Wang H; Liu CC; Wang X; Ran JC; Liang L; Lei L; Peng J; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Dec; 42(12):2156-2163. PubMed ID: 34954980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.